Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Oklahoma

Oklahoma has 81 clinical trials currently recruiting participants, ranking #35 among all states. The most-studied condition is Ovarian Cancer with 4 active trials.

81

Total Trials

81

Recruiting

#35

National Rank

13

Conditions

Trials by Phase

26

Not Applicable

2

Phase 2 / Phase 3

1

Early Phase 1

6

Phase 1 / Phase 2

13

Phase 1

15

Phase 2

11

Phase 3

7

Phase 4

Top Conditions in Oklahoma

Top Sponsors in Oklahoma

Cities With Most Trials in Oklahoma

#CityTrials
1Oklahoma City65
2Tulsa15
3Bartlesville1
4Enid1
5Moore1
6Edmond1
7Chickasha1

Important: This information is for research purposes only. Always talk to your doctor about whether a clinical trial is right for you.

Frequently Asked Questions

Oklahoma currently has 81 clinical trials actively recruiting participants, making it #35 nationally by total trial count.

The most-studied conditions in Oklahoma are Ovarian Cancer (4 trials), Asthma (2 trials), Gastric Cancer (2 trials).

Browse the conditions listed on this page to find trials recruiting in Oklahoma. Each condition page shows trial details, eligibility criteria in plain English, and contact information. Always talk to your doctor about whether a trial is right for you.

Trial counts reflect currently recruiting studies listed on ClinicalTrials.gov with locations in this state.

The this entity category groups every U.S. clinical trials and research registries entity sharing this attribute. The list above is the data; the paragraphs below explain what the grouping means against the broader the NIH ClinicalTrials.gov registry distribution and how to read the relative rankings within the category.

For readers using this category as a starting point, the per-entity detail pages linked from the table above carry the underlying the NIH ClinicalTrials.gov registry data in full. The category-level view is the filter; the per-entity pages are the actual answer.

Source: ClinicalTrials.gov, 2026.